These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35715856)

  • 1. A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy.
    Li M; Zhang J; Zha Y; Li Y; Hu B; Zheng S; Zhou J
    BMC Oral Health; 2022 Jun; 22(1):239. PubMed ID: 35715856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
    Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
    Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Pan XB; Liu Y; Huang ST; Chen KH; Jiang YM; Zhu XD
    Medicine (Baltimore); 2019 Sep; 98(36):e17030. PubMed ID: 31490391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.
    Zhao DW; Teng F; Meng LL; Fan WJ; Luo YR; Jiang HY; Chen NX; Zhang XX; Yu W; Cai BN; Zhao LJ; Wang PG; Ma L
    Radiother Oncol; 2023 Jul; 184():109683. PubMed ID: 37120102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
    Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
    Lee TF; Liou MH; Ting HM; Chang L; Lee HY; Wan Leung S; Huang CJ; Chao PJ
    Sci Rep; 2015 Aug; 5():13165. PubMed ID: 26289304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
    Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
    Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
    Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
    Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinoma.
    Wang M; Xi Y; Wang L; Chen H; Jiang F; Ding Z
    Radiat Oncol; 2024 Feb; 19(1):26. PubMed ID: 38418994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Needs and Benefits of Continuous Model Updates on the Accuracy of RT-Induced Toxicity Prediction Models Within a Learning Health System.
    Nakatsugawa M; Cheng Z; Kiess A; Choflet A; Bowers M; Utsunomiya K; Sugiyama S; Wong J; Quon H; McNutt T
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):460-467. PubMed ID: 30300689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.
    Yan G; Feng Y; Wu M; Li C; Wei Y; Hua L; Zhao G; Hu Z; Yao S; Hou L; Chen X; Liu Q; Huang Q
    Radiat Oncol; 2022 Jun; 17(1):111. PubMed ID: 35761414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
    Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
    PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
    Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using machine learning algorithms to predict the prognosis of advanced nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Hu D; Wang Y; Ji G; Liu Y
    Curr Probl Cancer; 2024 Feb; 48():101040. PubMed ID: 37979476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
    Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
    Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.